Suppr超能文献

与物质使用共病的精神障碍中精神病性症状缓解的预测因素。

Predictors of psychosis remission in psychotic disorders that co-occur with substance use.

作者信息

Caton Carol L M, Hasin Deborah S, Shrout Patrick E, Drake Robert E, Dominguez Boanerges, Samet Sharon, Schanzer Bella

机构信息

New York State Psychiatric Institute and the Department of Psychiatry, Columbia University, USA.

出版信息

Schizophr Bull. 2006 Oct;32(4):618-25. doi: 10.1093/schbul/sbl007. Epub 2006 Jul 27.

Abstract

OBJECTIVE

To examine rates and predictors of psychosis remission at 1-year follow-up for emergency admissions diagnosed with primary psychotic disorders and substance-induced psychoses.

METHOD

A total of 319 patients with comorbid psychosis and substance use, representing 83% of the original referred sample, were rediagnosed at 1 year postintake employing a research diagnostic assessment. Remission of psychosis was defined as the absence of positive and negative symptoms for at least 6 months. Likelihood ratio chi-square tests and multivariate logistic regression were the main means of analysis.

RESULTS

Of those with a baseline diagnosis of primary psychotic disorder, 50% were in remission at 1 year postintake, while of those with a baseline diagnosis of substance-induced psychosis, 77% were in remission at this time point. Lower Positive and Negative Syndrome Scale (PANSS) symptom levels at baseline, better premorbid functioning, greater insight into psychosis, and a shorter duration of untreated psychosis predicted remission at 1 year in both diagnostic groups. No interaction effects of baseline predictors and diagnosis type were observed. A stepwise multivariate logistic regression holding baseline diagnosis constant revealed the duration of untreated psychosis (odds ratio [OR] = 0.97; 95% confidence interval [CI] = 0.95, 0.997), total PANSS score (OR = 0.98; 95% CI = 0.97, 0.987), Premorbid Adjustment Scale score (OR = 0.13; 95% CI = 0.02, 0.88), and Scale to Assess Unawareness of Mental Disorders unawareness score (OR = 0.84; 95% CI = 0.71, 0.993) as key predictors of psychosis remission.

CONCLUSIONS

The association of better premorbid adjustment, a shorter duration of untreated psychosis, better insight into psychotic symptoms, and lower severity of psychotic symptoms with improved clinical outcome, reported previously in studies of schizophrenia, generalizes to psychosis remission in psychotic disorders that are substance induced.

摘要

目的

研究因原发性精神障碍和物质所致精神障碍而紧急入院的患者在1年随访时的精神病缓解率及预测因素。

方法

共有319例合并精神病和物质使用的患者(占原始转诊样本的83%),在入院1年后采用研究诊断评估进行重新诊断。精神病缓解定义为至少6个月无阳性和阴性症状。似然比卡方检验和多因素逻辑回归是主要分析方法。

结果

基线诊断为原发性精神障碍的患者中,50%在入院1年后缓解,而基线诊断为物质所致精神障碍的患者中,77%在该时间点缓解。两个诊断组中,基线时较低的阳性和阴性症状量表(PANSS)症状水平、较好的病前功能、对精神病的更好洞察力以及较短的未治疗精神病持续时间可预测1年时的缓解情况。未观察到基线预测因素与诊断类型的交互作用。在保持基线诊断不变的逐步多因素逻辑回归分析中,未治疗精神病的持续时间(比值比[OR]=0.97;95%置信区间[CI]=0.95,0.997)、PANSS总分(OR=0.98;95%CI=0.97,0.987)、病前适应量表评分(OR=0.13;95%CI=0.02,0.88)以及精神障碍自知力评估量表的自知力评分(OR=0.84;95%CI=0.71,0.993)是精神病缓解的关键预测因素。

结论

先前在精神分裂症研究中报道的病前适应更好、未治疗精神病持续时间更短、对精神病症状的洞察力更好以及精神病症状严重程度更低与临床结局改善之间的关联,在物质所致精神障碍的精神病缓解中同样适用。

相似文献

1
Predictors of psychosis remission in psychotic disorders that co-occur with substance use.
Schizophr Bull. 2006 Oct;32(4):618-25. doi: 10.1093/schbul/sbl007. Epub 2006 Jul 27.
2
Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse.
Nord J Psychiatry. 2004;58(3):237-42. doi: 10.1080/08039480410006296.
5
6
Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years.
Schizophr Bull. 2010 Sep;36(5):1001-8. doi: 10.1093/schbul/sbp007. Epub 2009 Mar 25.
7
Long-term course of substance use disorders among patients with severe mental illness.
Psychiatr Serv. 1995 Mar;46(3):248-51. doi: 10.1176/ps.46.3.248.
9
Psychotic patients with unclear diagnoses. A descriptive analysis.
J Nerv Ment Dis. 1995 Apr;183(4):207-13. doi: 10.1097/00005053-199504000-00004.

引用本文的文献

1
Psychosis Prognosis Predictor: A continuous and uncertainty-aware prediction of treatment outcome in first-episode psychosis.
Acta Psychiatr Scand. 2025 Mar;151(3):280-292. doi: 10.1111/acps.13754. Epub 2024 Sep 18.
4
Symptomatic and Functional Remission in Young Adults with a Psychotic Disorder in a Rehabilitation Focused Team.
Community Ment Health J. 2020 Apr;56(3):549-558. doi: 10.1007/s10597-019-00512-7. Epub 2019 Dec 9.
5
Encephalopathy or Psychosis?
Innov Clin Neurosci. 2016 Dec 1;13(11-12):41-42. eCollection 2016 Nov-Dec.
6
The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.
Schizophr Bull. 2017 Jul 1;43(4):843-851. doi: 10.1093/schbul/sbw179.
8
Personalized risk assessment of drug-related harm is associated with health outcomes.
PLoS One. 2013 Nov 6;8(11):e79754. doi: 10.1371/journal.pone.0079754. eCollection 2013.
9
Empirically Based Psychosocial Therapies for Schizophrenia: The Disconnection between Science and Practice.
Schizophr Res Treatment. 2013;2013:792769. doi: 10.1155/2013/792769. Epub 2013 Apr 23.

本文引用的文献

4
Value of early intervention in psychosis.
Br J Psychiatry. 2004 Aug;185:172; author reply 172-3. doi: 10.1192/bjp.185.2.172.
6
Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses.
Schizophr Bull. 2003;29(4):757-69. doi: 10.1093/oxfordjournals.schbul.a007045.
7
Duration of untreated psychosis: impact on 2-year outcome.
Psychol Med. 2004 Feb;34(2):277-84. doi: 10.1017/s0033291703001156.
8
Reducing the duration of untreated first-episode psychosis: effects on clinical presentation.
Arch Gen Psychiatry. 2004 Feb;61(2):143-50. doi: 10.1001/archpsyc.61.2.143.
9
Insight and recovery from psychosis in chronic schizophrenia and schizoaffective disorder patients.
J Psychiatr Res. 2004 Mar-Apr;38(2):169-76. doi: 10.1016/s0022-3956(03)00091-8.
10
Gender differences in schizophrenia.
Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:17-54. doi: 10.1016/s0306-4530(02)00125-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验